Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

S

SYRE

Spyre Therapeutics Inc

98.33

Jul 31 • 3:59 PM ET -3.17 (-3.12%)

98.33

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VB VXF IWO IBB VBR VTWO SCHA

Scroll to Statements

Index	RUT
Market Cap	8.54B
Enterprise Value	7.95B
Income	-168.74M
Sales	0.00M
Book/sh	6.53
Cash/sh	8.54
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	102
IPO	Apr 07, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	15.05
P/C	11.52
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.97
Current Ratio	8.97
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-2.36
EPS next Y	-3.21
EPS next Q	-0.76
EPS this Y	-52.11%
EPS next Y	-6.56%
EPS next 5Y	-23.61%
EPS past 3/5Y	57.01% 44.61%
Sales past 3/5Y	- -
EPS Y/Y TTM	22.31%
Sales Y/Y TTM	-
EPS Q/Q	-46.71%
Sales Q/Q	-
Earnings	May 05 BMO
EPS/Sales Surpr.	-11.18% -

Insider Own	10.82%
Insider Trans	-34.87%
Inst Own	82.85%
Inst Trans	-2.48%
ROA	-25.30%
ROE	-29.26%
ROIC	-25.15%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.18%
SMA50	12.17%
SMA200	87.71%
Trades

Shs Outstand	78.84M
Shs Float	77.45M
Short Float	16.15%
Short Ratio	9.37
Short Interest	12.51M
52W High	105.09 -6.43%
52W Low	14.51 577.90%
Volatility	6.51% 6.36%
ATR (14)	6.00
RSI (14)	53.87
Beta	3.02
Rel Volume	0.47
Avg Volume	1.34M
Volume	621,726

Perf Week	-3.72%
Perf Month	10.62%
Perf Quarter	32.08%
Perf Half Y	192.82%
Perf YTD	200.15%
Perf Year	479.43%
Perf 3Y	596.02%
Perf 5Y	-35.84%
Perf 10Y	-18.06%
Recom	1.19
Target Price	105.79
Prev Close	101.50
Price	98.33
Change	-3.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)